Vitro Biopharma, Inc. Quarterly Debt-to-equity in % from Q2 2014 to Q4 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Vitro Biopharma, Inc. quarterly Debt-to-equity history and growth rate from Q2 2014 to Q4 2024.
Vitro Biopharma, Inc. Debt-to-equity for the quarter ending January 31, 2025 was -169 %, a 79.1% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q4 2024	-169	+643	+79.1%	Jan 31, 2025
Q3 2024	-192	-1.7K	-113%	Oct 31, 2024
Q2 2024	-242	-706	-152%	Jul 31, 2024
Q1 2024	-344			Apr 30, 2024
Q4 2023	-812			Jan 31, 2024
Q3 2023	1.51K			Oct 31, 2023
Q2 2023	463			Jul 31, 2023
Q3 2015	-105	+1.2	+1.13%	Oct 31, 2015
Q2 2015	-105	+1	+0.95%	Jul 31, 2015
Q1 2015	-105			Apr 30, 2015
Q4 2014	-105			Jan 31, 2015
Q3 2014	-106			Oct 31, 2014
Q2 2014	-106			Jul 31, 2014

* An asterisk sign (*) next to the value indicates that the value is likely invalid.